After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints

[cafead]

via Merck has taken the lead, filing a lawsuit seeking to overturn drug pricing measures in the Inflation Reduction Act (IRA). Now, emboldened by the New Jersey drugmaker, the leaders of other companies are making their concerns public.

article source